Ceftiofur: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| IUPAC_name | | Watchedfields = changed | ||
| image | | verifiedrevid = 443443988 | ||
| IUPAC_name = (6''R'',7''R'')-7-[ [(2''Z'')-2-(2-Amino-1,3-thiazol-4-yl)- 2-methoxyiminoacetyl]amino]-3-(furan-2- carbonylsulfanylmethyl)-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |||
| | | image =Ceftiofur.png | ||
| | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|ceftiofur}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| | | pregnancy_US = <!-- A / B / C / D / X --> | ||
| pregnancy_category = | |||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | |||
| | | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> | ||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> | |||
| pregnancy_AU | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| pregnancy_US | | legal_status = | ||
| pregnancy_category= | | routes_of_administration = | ||
| legal_AU = | |||
| legal_CA = | <!--Pharmacokinetic data--> | ||
| legal_UK = | | bioavailability = | ||
| legal_US = | | protein_bound = | ||
| legal_status | | metabolism = | ||
| routes_of_administration = | | elimination_half-life = | ||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 80370-57-6 | |||
| ATCvet = yes | |||
| ATC_prefix = J01 | |||
| ATC_suffix = DD90 | |||
| ATC_supplemental = {{ATCvet|J51|DD90}} | |||
| PubChem = 6328657 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 4886668 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 83JL932I1C | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D07657 | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 222913 | |||
<!--Chemical data--> | |||
| C=19 | H=17 | N=5 | O=7 | S=3 | |||
| molecular_weight = 523.56 g/mol | |||
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)CSC(=O)c4occc4)C(=O)O | |||
| InChI = 1/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11-/t12-,16-/m1/s1 | |||
| InChIKey = ZBHXIWJRIFEVQY-IHMPYVIRBM | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11-/t12-,16-/m1/s1 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = ZBHXIWJRIFEVQY-IHMPYVIRSA-N | |||
}} | |||
__Notoc__ | __Notoc__ | ||
{{SI}} | {{SI}} |
Latest revision as of 13:26, 10 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATCvet code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H17N5O7S3 |
Molar mass | 523.56 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Ceftiofur |
Articles |
---|
Most recent articles on Ceftiofur |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ceftiofur at Clinical Trials.gov Clinical Trials on Ceftiofur at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ceftiofur
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Ceftiofur Discussion groups on Ceftiofur Directions to Hospitals Treating Ceftiofur Risk calculators and risk factors for Ceftiofur
|
Healthcare Provider Resources |
Causes & Risk Factors for Ceftiofur |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ceftiofur is an antibiotic of the cephalosporin type (third generation), licensed for use in veterinary medicine. It was first described in 1987.[1] It is marketed by pharmaceutical company Pfizer as Excede.[2]
It is resistant to the antibiotic resistance enzyme beta-lactamase, and has activity against Gram-positive and Gram-negative bacteria. E. coli strains resistant to ceftiofur have been reported.[3]
References
- ↑ Yancey RJ, Kinney ML, Roberts BJ, Goodenough KR, Hamel JC, Ford CW (1987). "Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice". Am. J. Vet. Res. 48 (7): 1050–3. PMID 3631686.
- ↑ "Pfizer Animal ealth Dairy Information on Products and Solutions". Retrieved 2007-11-20.
- ↑ Donaldson SC, Straley BA, Hegde NV, Sawant AA, DebRoy C, Jayarao BM (2006). "Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves". Appl. Environ. Microbiol. 72 (6): 3940–8. doi:10.1128/AEM.02770-05. PMID 16751500.
External links
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Drug
- Cephalosporin antibiotics
- Furans
- Thiazoles